Recombinant Human B-cell Receptor CD22/Siglec-2/CD22 (C-6His) Biotinylated

Introducing the Recombinant Human B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) Biotinylated, a highly advanced and innovative product designed to meet the needs of the modern scientific community. This product is a recombinant protein that has been specifically engineered to target the B-cell receptor CD22/SIGLEC-2/CD22 (C-6HIS) and is biotinylated for enhanced detection and analysis.

The Recombinant Human B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) Biotinylated is a highly purified and homogeneous protein that has been produced using state-of-the-art recombinant DNA technology. It is a highly stable and biologically active protein that is suitable for a wide range of applications, including research, diagnostics, and therapeutics.

This product is supplied in a convenient and easy-to-use format, making it ideal for use in a variety of laboratory settings. It is also highly customizable, allowing researchers to tailor its properties to suit their specific needs and requirements.

Overall, the Recombinant Human B-Cell Receptor CD22/SIGLEC-2/CD22 (C-6HIS) Biotinylated is a cutting-edge product that represents the latest advances in biotechnology. It is a must-have for any researcher or scientist looking to stay at the forefront of their field and make groundbreaking discoveries.